Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)
Close on Nov 18, 2026Market cap $546.32MP/E –Yield –
Wave Life Sciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Wave Life Sciences's market cap was $661.01M on Nov 11, 2026, against $1.49B a year earlier. Over the last 5 years it ranged from $85.20M to $2.72B, with a median of $607.89M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $661.01M | -75.7% |
| 2025 | Dec 31, 2025 | $2.72B | +48.4% |
| 2024 | Dec 31, 2024 | $1.84B | +267.1% |
| 2023 | Dec 29, 2023 | $500.01M | -17.7% |
| 2022 | Dec 30, 2022 | $607.89M | +272.3% |
| 2021 | Dec 31, 2021 | $163.27M | -57.5% |
| 2020 | Dec 31, 2020 | $383.81M | +39.7% |
| 2019 | Dec 31, 2019 | $274.79M | -77.8% |
| 2018 | Dec 31, 2018 | $1.24B | +26.9% |
| 2017 | Dec 29, 2017 | $974.65M | +58.8% |
| 2016 | Dec 30, 2016 | $613.85M | +317.3% |
| 2015 | Dec 31, 2015 | $147.11M | – |
See a number that looks wrong?